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he superior cervical ganglion (SCG) is a well-characterized model of neural development, in which several regulatory
ignals have been identified. Vasoactive intestinal peptide (VIP) has been found to regulate diverse ontogenetic processes in
ympathetics, though functional requirements for high peptide concentrations suggest that other ligands are involved. We
ow describe expression and functions of pituitary adenylate cyclase-activating polypeptide (PACAP) during SCG ontogeny,
uggesting that the peptide plays critical roles in neurogenesis. PACAP and PACAP receptor (PAC1) mRNA’s were detected
t embryonic days 14.5 (E14.5) through E17.5 in vivo and virtually all precursors exhibited ligand and receptor, indicating
hat the system is expressed as neuroblasts proliferate. Exposure of cultured precursors to PACAP peptides, containing 27
r 38 residues, increased mitogenic activity 4-fold. Significantly, PACAP was 1000-fold more potent than VIP and a highly
otent and selective antagonist entirely blocked effects of micromolar VIP, consistent with both peptides acting via PAC1
receptors. Moreover, PACAP potently enhanced precursor survival more than 2-fold, suggesting that previously defined VIP
effects were mediated via PAC1 receptors and that PACAP is the more significant developmental signal. In addition to
eurogenesis, PACAP promoted neuronal differentiation, increasing neurite outgrowth 4-fold and enhancing expression of
eurotrophin receptors trkC and trkA. Since PACAP potently activated cAMP and PI pathways and increased intracellular
a21, the peptide may interact with other developmental signals. PACAP stimulation of precursor mitosis, survival, and trk
receptor expression suggests that the signaling system plays a critical autocrine role during sympathetic neurogenesis.
© 2000 Academic Press
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During nervous system development, neuronal popula-
tions are generated according to characteristic spatial and
temporal patterns, suggesting precise regulatory mecha-
nisms (Jacobson, 1991). Extracellular factors provide one
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All rights of reproduction in any form reserved.ajor source of neurogenetic control. Environmental sig-
als may regulate three distinct mechanisms in neuronal
recursors to promote growth of stable populations
DiCicco-Bloom, 1996). First, factors may stimulate precur-
ors or neuroblasts to enter the cell division cycle, a
raditional mitogenic function (Baserga, 1985; DiCicco-
loom and Black, 1988; Pardee, 1989). Second, recent evi-
ence indicates that molecules may enhance cell produc-
ion by preventing the death of mitotic precursors, allowing
ompletion of division, yielding cell accumulation (Drago
197
e
a
p
m
D
g
s
t
1
b
r
1
G
a
c
t
n
T
(
t
w
i
T
n
a
a
C
i
c
h
p
f
s
(
w
o
e
t
p
(
r
p
P
t
b
m
a
w
c
b
c
c
s
e
r
198 DiCicco-Bloom et al.et al., 1991; Birren et al., 1993; DiCicco-Bloom et al., 1993;
Pincus et al., 1994). Finally, signals may promote long-term
maintenance of generated neurons by promoting expression
of receptors for target-derived survival factors (Davies,
1997). Naturally, signals influencing these distinct pro-
cesses in mitotic precursors temporally precede effects of
target-derived trophic factors that act on innervating, post-
mitotic neurons.
In the sympathetic lineage, a number of signals control-
ling these ontogenetic events have been identifed, factors
that act at different stages to regulate development. NGF is
the well-characterized, target-derived factor that promotes
survival of innervating sympathetic neurons (Levi-
Montalcini, 1987; Crowley et al., 1994). The high-affinity
component of the receptor complex, trkA (Chao, 1992),
appears late during ganglion development, mRNA levels
increasing markedly by birth (Birren et al., 1993; DiCicco-
Bloom et al., 1993; Wyatt and Davies, 1995). On the other
hand, prior to target contact, proliferating precursors and
newly postmitotic neurons respond to a variety of extracel-
lular signals, exhibiting distinct and/or overlapping activi-
ties, including vasoactive intestinal peptide (VIP); NT3;
IGF; CNTF; glial cell line-derived neurotrophic factor
(GDNF) family members GDNF, neurturin, and artemin;
and hepatocyte growth factor (HGF) (DiCicco-Bloom and
Black, 1988, 1989; Ernsberger et al., 1989; DiCicco-Bloom
et al., 1990; Lee et al., 1991; Buj-Bello, 1995; Trupp et al.,
1995; Zachenfels et al., 1995; Durbec et al., 1996; Creedon
t al., 1997; Baloh et al., 1998; Maina et al., 1998; Yang et
l., 1998; Forgie et al., 1999). For example, NT3, which acts
rimarily via the trkC receptor, stimulates survival of the
itotic precursor population in culture (Birren et al., 1993;
iCicco-Bloom et al., 1993), but is devoid of direct mito-
enic activity (Lu et al., 1996). However, genetic deletion
tudies indicate that NT3 supports survival only of postmi-
otic neurons after neurogenesis (Wyatt et al., 1997; Davies,
997). HGF, acting as an autocrine factor, promotes survival
ut not mitosis of prenatal neuroblasts and enhances neu-
ite outgrowth and branching postnatally (Maina et al.,
998; Yang et al., 1998). GDNF, neurturin, and artemin
signal via Ret tyrosine kinase in combination with GFRa-1,
FRa-2, and GFRa-3, respectively, to stimulate survival
and differentiation of overlapping populations of prenatal
and postnatal neurons (Buj-Bello et al., 1995; Trupp et al.,
1995; Moore et al., 1996; Creedon et al., 1997; Granholm et
l., 1997; Baloh et al., 1998; Forgie et al., 1999). In contrast,
VIP stimulates multiple processes prenatally, during the
period of neurogenesis: the peptide promotes neuroblast
mitosis, precursor survival, and morphologic differentia-
tion, acting at a developmental stage preceding effects of
NGF (Pincus et al., 1990a,b, 1994). The overlapping trophic
effects of VIP and the neurotrophins raises questions regard-
ing factor relationships. In particular, does early VIP action
on sympathetic neuroblasts affect neurotrophin receptor
expression?From another perspective, while VIP stimulates precursor
development, the peptide is effective in the micromolar
Copyright © 2000 by Academic Press. All rightoncentration range (Pincus et al., 1990a,b), uncharacteris-
ic for actions via high-affinity receptors. Is there an alter-
ative molecular signal regulating sympathetic precursors?
he pituitary adenylate cyclase-activating polypeptides
PACAPs) are recently discovered neuropeptides with ex-
ensive homology to VIP (Arimura, 1992). The peptides
ere isolated from hypothalamic extracts using cAMP
nduction in pituitary cells as bioassay (Miyata et al., 1989).
here are two molecular forms, apparently reflecting alter-
ative processing of a single gene product. The 27-amino-
cid peptide (PACAP27) has 68% identity with the 28-
mino-acid VIP, while PACAP38 possesses an additional 11
-terminal residues. PACAP38, the major form expressed
n the peripheral and central nervous system, is absolutely
onserved at the amino acid level in rodent, porcine, and
uman species (Arimura, 1992), suggesting important
hysiologic functions. Consistent with such a role, we
ound that PACAP potently stimulated differentiation in
ympathoadrenal tumor lines, neuroblastoma and PC12
Deutsch and Sun, 1992; Deutsch et al., 1993). Moreover,
e recently detected PACAP protein and mRNA in embry-
nic sympathetic ganglia (Lu and DiCicco-Bloom, 1997; Lu
t al., 1998), though effects in the primary neurons remain
o be defined.
The recognition that the highly related VIP and PACAP
eptides are expressed in the superior cervical ganglion
SCG) raises the possibility of interactions at cellular
eceptors. Indeed, two receptor classes are described
harmacologically: PACAP type I receptors bind
ACAP27 and PACAP38 two to three orders of magni-
ude more potently than VIP, whereas type II receptors
ind the three peptides with approximately equal nano-
olar affinities (Arimura, 1992; Christophe, 1993). There
re three receptor genes identified by molecular cloning,
ith PAC1 receptor corresponding to type I sites and
VPAC1 and VPAC2 (previously termed “VIP receptors”)
orresponding to type II (Harmar et al., 1998). As mem-
ers of the seven-transmembrane domain, G-protein-
oupled receptor family, all the receptors positively
ouple to cAMP, whereas PAC1 activates phosphatidyl
inositol (PI) pathways as well (Pisegna and Wank, 1993;
Spengler et al., 1993; Arimura and Shioda, 1995; Rawl-
ings and Hezareh, 1996). Further, the PAC1 receptor has
ix mRNA splice variants, which determine coupling
fficiency to PI signaling (Spengler et al., 1993). We
ecently defined PAC1 expression in the embryonic SCG,
detecting the “hop” isoform known to couple to cAMP
and PI pathways (Lu et al., 1998; Spengler et al., 1993),
though whether embryonic sympathetics can support
such signaling remains undefined. The current studies,
defining PACAP ligand/receptor expression, ontogenetic
funcions, and mediating intracellular signals, suggest
that the peptide system serves an autocrine regulatory
role during a critical embryonic period of sympathetic
development. An initial report has appeared (DiCicco-
Bloom and Deutsch, 1992).
s of reproduction in any form reserved.
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199PACAP Regulation of Sympathetic DevelopmentMETHODS
Preparation of Cultures
Serum-free cultures composed of both mitotic and nonmitotic
sympathetic precursors or neuroblasts were obtained from SCG of
15.5-day embryonic (E15.5) rats as previously described (DiCicco-
Bloom and Black, 1988; DiCicco-Bloom et al., 1990, 1993; Pincus et
al., 1990a,b, 1994). Ganglia were enzymatically and mechanically
dissociated and cells were plated on poly(D)-lysine- (0.1 mg/ml)
coated 35-mm culture dishes (two to three ganglia or approxi-
mately 30–45,000 cells/dish) or 24-well plates (one ganglion/well)
in fully defined medium lacking insulin as described. For Ca21
imaging studies, neuroblasts were cultured on poly(D)-lysine- (0.1
mg/ml) coated 12-mm glass coverslips incubated in 35-mm culture
dishes. Culture medium was prepared as previously reported
(DiCicco-Bloom et al., 1993) and was composed of the following:
50/50 mixture of Ham’s F-12 and Dulbecco’s modified Eagle’s
medium, penicillin (50 units/ml), streptomycin (50 mg/ml), trans-
ferrin (100 mg/ml), putrescine (100 mM), progesterone (20 nM),
selenium (30 nM), glutamine (2 mM), glucose (6 mg/ml), and
bovine serum albumin (10 mg/ml). In studies of differentiation,
insulin was included at concentrations that elicited maximal
mitogenic stimulation, 10 mg/ml (DiCicco-Bloom and Black, 1988;
iCicco-Bloom et al., 1990; Pincus et al., 1994). For prolonged
ultures, factors were added again at 2 days.
Thymidine ([3H]dT) Incorporation Assays
DNA synthesis was used as a marker for cells in the mitotic
cycle (DiCicco-Bloom and Black, 1988; Pincus et al., 1990a,b;
DiCicco-Bloom et al., 1990, 1993). After addition of [3H]dT (1
mCi/ml), polymerized DNA containing incorporated radiolabel was
collected onto glass fiber filters using a semiautomatic cell har-
vester (Skatron), while unincorporated [3H]dT was removed by
exhaustive water elution (Pincus et al., 1990). These methods
reproduce results obtained previously with TCA precipitation
(DiCicco-Bloom and Black, 1988; DiCicco-Bloom et al., 1990).
Cultures incubated with [3H]dT for 30 min at 37°C or overnight at
°C exhibited only background counts, 12–15 cpm, whereas the
NA polymerase inhibitor, aphidicolin, decreased incorporation at
7°C by .90%. For 48-h cultures, [3H]dT was added at 24 h of
ncubation and incorporation was assayed at 48 h by scintillation
pectroscopy. For 24-h experiments, [3H]dT was added at 20 h
DiCicco-Bloom et al., 1993), whereas for 6-h studies, [3H]dT was
added at 4 h (Lu et al., 1996). Three to four culture wells were
employed for each group in each experiment, and experiments were
performed at least three times, unless stated otherwise.
Bromodeoxyuridine (BrdU) Mitotic Labeling Index
To visualize cells synthesizing DNA, cultures were exposed to
BrdU (10 mM) during the final 2 h of a 6-h incubation (Lu et al.,
996; Lu and DiCicco-Bloom, 1997). After fixation with 4% para-
ormaldehyde for 20 min and rinsing, cells were exposed to 2 N HCl
30 min), rinsed twice in phosphate-buffered saline (PBS), incubated
or 1 h (21°C) in monoclonal anti-BrdU (1:50, Dako) in PBS/0.3%
riton X-100, and visualized using Vectastain ABC immunoperox-
dase kit (Vector Laboratories, Burlingame, CA).The labeling index
LI), defined as the proportion of total cells incorporating BrdU into
he nucleus, was determined by scoring 200 cells from randomly
elected, nonoverlapping fields in each of three dishes/group in two
xperiments.
Copyright © 2000 by Academic Press. All rightCell Counting, Neurite Outgrowth, and
Photography
Living cultures were examined with a Zeiss inverted phase
microscope at 2003 or 3203. Three 35-mm culture dishes were
examined for each experimental group in each experiment. To
assess overall neuron numbers, living cells in two to three ran-
domly selected, nonoverlapping 1-cm strips were counted (1.3–3%
of the culture dish area, yielding counts of 300–600 cells per dish)
at 24 h as described (DiCicco-Bloom et al., 1993). To assess neurite
utgrowth, cells (cultured with insulin, 10 mg/ml) were scored at
24 h for the presence of processes .2 cell body diameters in two
experiments, N 5 6 dishes. To establish the number of cells
initially plated (zero time), cells were counted 2–3 h after plating. In
some experiments, fixed cells were counted after immunocyto-
chemistry. Selected fields were photographed with a 35-mm cam-
era. For publication, negative and Kodachrome images were im-
ported into Adobe Photoshop software for printing.
Immunocytochemistry
Following 4% paraformaldehyde fixation (20 min), cultures were
washed three times with PBS, blocked with 10% normal goat
serum/PBS, and incubated overnight with well-characterized rabbit
antisera to PACAP and Type I (PAC1) receptor (1:5000 and1:1000;
Lu and DiCicco-Bloom, 1997; provided by A. Arimura, Tulane
University) and trkA and trkC (Santa Cruz). In addition, antibodies
raised against peptides specific to trkC and trkA intracellular and
extracellular domain sequences, as previously described (Belliveau
et al., 1997), were provided by D. Kaplan including trkAout,
trkAin2, trkCout, and trkCin2 (1:500–1:1000; D. Kaplan, Montreal
Neurologic Institute). After incubating cells with biotinylated goat
anti-rabbit antiserum (1:200–1:500), immunostaining was visual-
ized with the Vector Laboratories ABC immunoperoxidase kit. All
studies included a control dish incubated without primary anti-
body and assessment of positive and negative staining cells to
evaluate specificity. PACAP antibody specificity was assessed by
preincubating antiserum with 17 mM PACAP, VIP, secretin, or
eptide-His-Ile (PHI) 18 h before use, which indicated that only
ACAP depleted immunoreactive signal.
To assess cellular-immunoreactive staining, we examined both
he cytoplasmic localization and the signal intensity and found
enerally two major classes. In the first case, signal was restricted
o the perinuclear envelope and a crescent of granular cytoplasm,
hich presumably reflected the Golgi organ in these immature
ells in culture, as previous identified by electron microscopy
DiCicco-Bloom et al., 1990). This restricted signal was of weak
ntensity in the large majority of cases. In the second class, staining
as distributed circumferentially around the nucleus and homoge-
eously throughout the cytoplasm and neuritic processes. This
mmunoreactive signal was intense. While both classes of cells
ere present in all experimental groups, proportions were mark-
dly altered by extracellular factors. Each experiment consisted of
–4 dishes per group, and cells were counted as above. Each
nalysis was performed at least three times, yielding N 5 9–12
dishes for each antigen assessed.
Western Analysis of Trk Proteins
Neuroblasts dissociated from 40–50 SCG were incubated in
35-mm dishes in control (10 mg/ml insulin) or PACAP-containing
medium. At 24 h, cells were scraped and lysed in buffer solution
s of reproduction in any form reserved.
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200 DiCicco-Bloom et al.containing 1% Triton X-100, 0.9% NaCl, protease inhibitor solu-
tion (Boehringer Mannheim), and 0.05 M vanadate in 0.02 M
Sorrenson’s buffer. After combining and concentrating several
culture samples, protein concentration was determined using the
Coomassie Plus protein assay (Pierce, Rockford, IL), with a corre-
sponding aliquot of lysis buffer in the BSA standard. Duplicate
samples (25–65 mg protein/lane) from control and PACAP-treated
culture extracts received 2-mercaptoethanol (5%), and were heated
to 100°C for 5 min and run on 7.0% acrylamide gel overnight. In
addition to duplicate loading, two parallel gels were run in most
cases. Proteins were transferred at 37°C for 1.5 h to PVDF mem-
branes (Millipore, Bedford, MA) using a semidry system. Filters
were incubated with anti-trkAout or trkAin2 (1:1000; D. Kaplan,
Montreal Neurologic Institute) or anti-RNA polymerase II (210-
kDa subunit; D. Reinberg, Robert Wood Johnson Medical School)
overnight at 4°C on an orbital shaker and secondary anti-rabbit IgG
(1:5000; Amersham, Arlington Heights, IL) for 1 h at room tem-
perature. Blots were washed four times with Tris-buffered saline
(pH 7.6)/0.1% Tween 20 at 37°C at 15-min intervals after antibody
incubations. Bands were visualized using the ECL method (NEN,
Boston, MA) and detected on high-performance chemilumines-
cence film (Amersham) after 1–15 min of exposure, using a Kodak
automatic developer. In some cases, probed filters were subse-
quently stained for protein using Coomassie blue. Final figures
were captured with a UMAX desktop scanner, attached to a Power
MacIntosh G3, using Adobe Photoshop 4.0. Cultures from four
experiments were probed for trkA on three blots.
In Situ Hybridization
In situ hybridizations were performed as previously described
(Zhang et al., 1997). Embryos (E12.5–E17) were freshly frozen and
embedded in OCT compound without prior fixation. Consecutive
serial cryostat sections (10 mM), sagittal and transverse, were
produced and hybridized with probes described below. At least two
embryos from each stage were examined and produced identical
results. 35S-labeled cRNA probes were transcribed in vitro from
lasmid vectors using the Riboprobe Gemini system from Promega
Madison, WI). The PACAP probe was transcribed from pRB3Z3,
ollowing linearization with HindIII and can recognize both
ACAP38 and PACAP27 forms (Ohkubo et al., 1992). Another
ACAP probe was generated after linearization with PstI from the
ame plasmid vector and yielded identical results. The PAC1 probe
as transcribed from pBSks, linearized with EcoRI. This probe can
ybridize with all six alternately spliced PAC1 transcripts (Spengler
et al., 1993). In all cases, control (sense) RNA probes did not
produce signal in adjacent sections.
cAMP Assay
cAMP levels were determined by radioimmunoassay using anti-
cAMP antibodies (Biomedical Technologies, Stoughton, MA), sepa-
rating bound from free ligand by precipitation with 10.5% polyeth-
ylene glycol, as previously described (Deutsch and Sun, 1992). In
these experiments, we cultured dissociated neuroblasts (five
ganglia/dish) for 24 h. To assay cAMP content, cells were pre-
treated with 500 mM isobutylmethylxanthine for 5 min, and
incubated with peptides for 10 min, and then collected as previ-
ously described. Triplicate samples of all groups were assayed in
two separate experiments, run in parallel with a standard curve,
and data represent a sum of the six values per group.
a
p
Copyright © 2000 by Academic Press. All rightInositol Lipid Turnover
Lipid turnover was measured by quantitating total inositol
phosphates as previously reported (Deutsch and Sun, 1992). After
24 h of incubation of dissociated neuroblasts (four ganglia/dish) in
medium containing 3 mCi/ml [myo-3H]inositol (19 Ci/mmol, Am-
rsham), cultures were pretreated with LiCl (10 mM) for 3 min and
hen stimulated with the peptides. Reactions were terminated at 30
in by adding 1 ml of methanol:10 mM EDTA:HCl (100:60:1,
/v/v). After addition of 0.75 ml of chloroform, aqueous and organic
hases were separated. Inositol phosphates, partitioned in the
queous phase, were separated from free inositol by ion-exchange
hromatography and elution with 1 M ammonium formate, 33 mM
ormic acid, and quantitated by liquid scintillation counting. The
otal 3H-lipid content was assessed in aliquots of oganic phase and
did not differ among samples. The data represent the mean of three
samples per group in three separate experiments.
Fluorescence Imaging of Intracellular Ca21
Concentrations ([Ca21]I)
The [Ca21]i in cultured neuroblasts were directly monitored
sing Fura-2 ratio imaging method (Zheng et al., 1994). Briefly,
euroblasts grown on glass coverslips were incubated with culture
edium containing 10 mM Fura-2/AM for 30 min at 37°C. After
hree careful rinses with culture medium, coverslips were mounted
n the stage of an inverted microscope equipped with a ratiometric
maging system. The imaging system consisted of a cooled CCD
amera (PXL1400, Photometrics, Tuscon, AZ), a filter wheel with
uilt-in shutter (LAMBDA 10-2, Sutter Instruments, Co., Novato,
A), and imaging software running on a Pentium PC (Axon
maging Workbench, Axon Instruments, Inc., Foster City, CA).
ura-2 ratio imaging was performed using excitation wavelengths
f 340 and 380 nm, with an exposure time of 100 ms at each
avelength.
Statistical Analysis
Data were analyzed by Student’s t test or one-way analysis of
variance (ANOVA) and Scheffe f test using the Statworks and
Statview programs, respectively, on a Macintosh IIcx or Performa
computer.
RESULTS
Expression of PACAP Peptide and PAC1 Receptor
uring Ganglion Development
To examine the ontogenetic role of the PACAP system,
we characterized expression of ligand/receptor mRNA and
protein in the ganglion. Neural crest progenitor cells of the
SCG cease migrating and aggregate dorsolateral to the
paired dorsal aortas at E11.5–E12, expressing neurotrans-
mitter biosynthetic enzymes and catecholamines while
undergoing proliferation (Cochard et al., 1979; Rothman et
l., 1978, 1980; Rohrer and Thoenen, 1987; DiCicco-Bloom
t al., 1990, 1993). PACAP ligand and receptor mRNA
ranscripts were not detected in vivo at E12.5, the earliest
ge examined (data not shown). Two days later when
roliferation predominates (E14.5), peptide transcripts were
s of reproduction in any form reserved.
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201PACAP Regulation of Sympathetic Developmentexpressed diffusely in both the SCG and the neighboring
nodose ganglion, while receptors were restricted to the
sympathetic precursors (Fig. 1), consistent with neuron
responsiveness to PACAP in culture (E. DiCicco-Bloom,
unpublished observation). Receptor transcripts were main-
tained in the SCG at E17.5, though PACAP mRNA expres-
sion decreased, paralleling reductions in sympathetic neu-
rogenesis (Pincus et al., 1994). In contrast, PACAP mRNA
expression continued in the nodose ganglion, suggesting
distinct roles for PACAP during peripheral ganglion devel-
opment.
To characterize protein expression, we examined precur-
sors at the cellular level using immunocytochemistry. As
both PACAP and PAC1 receptor transcripts in vivo were
rominent and diffuse, we estimated proportions of E15.5
ells expressing proteins after acute ganglion dissociation,
xing cells following attachment at 2–3 h. This approach,
hich removes nonneurons and presynaptic fibers, has
een used successfully to estimate expression of neuronal
ntigens detected in diffuse patterns in vivo, including
yrosine hydroxylase, neurofilament, tetanus toxin recep-
ors, and Q211 (Cochard et al., 1979; Rothman et al., 1978,
980; Rohrer and Thoenen, 1987; DiCicco-Bloom and
lack, 1988; DiCicco-Bloom et al., 1990, 1993). While there
as some variability in staining intensity, greater than 95%
f cells expressed both PACAP and PAC1 receptor immu-
oreactivity at 3 h (PACAP, 97.5 6 0.3%; PAC1 receptor,
95.8 6 1.1%), suggesting that the peptide system functions
n autocrine/paracrine fashion in the ganglion in vivo (Fig.
). Moreover, after 24 h of incubation, similar proportions
xhibited ligand and receptor staining (PACAP, 98.1 6
.9%; PAC1 receptor, 97.0 6 1.0%), indicating that exog-
enous factors, such as the neurotrophins, were not required
to maintain system expression (Fig. 2). Peptide and receptor
were expressed by cells exhibiting simple forms as well as
those bearing neuritic processes. As 12 to 25% of E15.5
precursors are engaged in S-phase of the mitotic cycle in
vivo and in vitro as a function of mitogenic factors
(DiCicco-Bloom and Black, 1988; DiCicco-Bloom et al.,
1990, 1993), the PACAP signaling system may directly
affect cell proliferation. In turn, we analyzed PACAP effects
on ganglion neurogenesis.
PACAP Effects on Sympathetic Neuroblast Mitosis
and Survival
To define PACAP effects on SCG development, ganglion
cells were cultured under fully defined conditions as char-
acterized previously (see Methods). In these cultures,
greater than 97% of cells express neuronal markers, ty-
rosine hydroxylase, the catecholamine biosynthetic en-
zyme, and MAP2 (DiCicco-Bloom et al., 1990, 1993). To
examine effects on mitosis, cells were incubated in control
medium or media containing various concentrations of the
two PACAP peptides, PACAP27 or PACAP38, and incorpo-
3ration of [ H]dT, a marker for DNA synthesis, was assessed
at 48 h. Both peptides increased incorporation greater than i
Copyright © 2000 by Academic Press. All right-fold (Fig. 3A), suggesting that PACAP peptides stimulate
recursor mitosis. Since the peptides exhibited parallel
ose–response curves, we performed further studies with
ACAP38, the more abundant ligand (Arimura, 1992). To
efine relationships of PACAP to VIP in mitogenic stimu-
ation, we performed parallel dose–response analysis and
dditivity experiments. PACAP exhibited an EC50 5 1 nM
hereas that of VIP was EC50 5 1 mM, indicating that
ACAP was a 1000-fold more potent (Fig. 3B). Furthermore,
aximal concentrations of PACAP and VIP were not addi-
ive (Fig. 3C), suggesting that the peptides stimulate incor-
oration in the same or overlapping subpopulations. Signifi-
antly, the absence of VIP effects in the nanomolar dose
ange indicates that neuroblasts do not possess functional
PAC receptors linked to mitogenesis (Christophe, 1993;
rimura and Shioda, 1995; Rawlings and Hezareh, 1996;
armar et al., 1998).
To further define receptor mechanisms, we employed the
AC1-selective receptor antagonist, PACAP6-38, in 24-h cul-
ture paradigms, as used previously (Robberecht et al., 1992;
Lu and DiCicco-Bloom, 1997). The antagonist markedly
reduced stimulation of DNA synthesis elicited by PACAP
at 24 h, consistent with peptide and antagonist action via
the PAC1 receptor (Fig. 3D). Significantly, the same concen-
tration of PACAP antagonist completely abolished mito-
genic stimulation elicited by VIP, indicating that at
equimolar concentrations, no VIP effect was observed.
Furthermore, even at a 10-fold lower dose, the PAC1 recep-
tor antagonist prevented VIP stimulation (Fig. 3E), consis-
tent with the model of VIP as a low-affinity, heterologous
ligand acting via PAC1 receptor to stimulate sympathetic
itosis (Robberecht et al., 1992; Christophe, 1993; Rawl-
ngs and Hezareh, 1996).
In addition to DNA synthesis, we examined PACAP
ffects on cell number. Previous study indicated that VIP
nhanced neuroblast survival independent of mitotic ef-
ects, because (1) long-term increases (3–4 days) in cell
umber occurred even in the presence of inhibitors of DNA
olymerase (Pincus et al., 1990a), and (2) even in the
resence of maximal mitogenic stimulation with insulin,
IP promoted survival of both mitotic and nonmitotic
euroblasts (Pincus et al., 1994). In the current study, only
8% of neuroblasts survived in control media after 24 h of
ncubation, similar to previous results (DiCicco-Bloom et
l., 1993; Lu et al., 1996). In contrast, more than twice as
any of the plated cells, 90%, were present after PACAP
reatment, suggesting that PACAP has trophic activity (Fig.
). Furthermore, PACAP increased cell number up to 50%
ven in the presence of mitogenic stimulation by insulin
see below). Finally, as observed with 3 mM VIP (also Pincus
t al., 1990a,b), 10 nM PACAP increased cell number three-
o fourfold at 3 days (control 822 6 45; VIP 2100 6 107;
ACAP 3000 6 102; mean number 6 SEM, P , 0.001),
uggesting that the peptides exhibit comparable trophic
ffects.
The detection of PACAP mitogenic and trophic activity
n the foregoing 24-h studies, however, leads to interpretive
s of reproduction in any form reserved.
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203PACAP Regulation of Sympathetic Developmentdifficulties regarding mechanisms by which the peptide
increases [3H]dT incorporation. While PACAP may “in-
truct” cells to enter S-phase of the cell cycle, a traditional
itogenic action, the peptide may also “select” for survival
hose precursors already committed to synthesize DNA,
erely allowing cells to survive long enough to be counted
Lu et al., 1996). To clarify this issue, we used a previously
efined paradigm that minimizes survival promotion, by
xamining cultures prior to the onset of major cell death.
ew cells die by 6 h, allowing comparison of DNA synthesis
n similar cell populations (Lu et al., 1996). PACAP in-
reased [3H]dT incorporation 32% in 6 h (control 142 6 6.6;
PACAP 187 6 7.3; mean cpm 6 SEM; N 5 18, three
experiments, P , 0.0001), indicating rapid peptide signal-
ing. Though of small magnitude, these effects are compa-
rable to the sympathetic mitogen insulin, which main-
tained ongoing DNA synthesis in this culture paradigm,
whereas the control group progressively exited the cycle (Lu
et al., 1996). Further, PACAP elicited a 17% increase in the
mitotic labeling index (BrdU LI, control 20.7 6 0.8%,
ACAP 24.2 6 1.3%; mean % 6 SEM; N 5 6, two
experiments; P , 0.04), whereas there was no difference in
cell numbers between the groups (cell number, control
337 6 7.6;, PACAP 336 6 6.9; mean number 6 SEM; N 5 6,
two experiments), suggesting that more cells crossed the
G1/S-phase boundary following PACAP exposure. Thus,
PACAP system activation increases both mitosis and pre-
cursor survival, the two major mechanisms underlying
enhanced production of neuronal populations (DiCicco-
Bloom et al., 1993; Lu et al., 1996).
PACAP Effects on Trk Receptor Expression and
Neurite Outgrowth
Following generation of ganglion neurons by precursor
division, population growth depends on immediate and
longer term cell survival, due to local as well as target-
derived trophic factors. Of a variety of factor families,
FIG. 1. Localization of PACAP and PAC1 mRNA transcripts in e
(B, C, E, F) images of sections through the dorsal cervical region
hybridized embryo shown in B, stained with H & E. (B) PACAP m
nodose (Nod) ganglion, which lie medial and lateral respectively to
(DRG) and spinal cord (SC), primarily in regions of postmitotic ne
ranscripts are highly expressed in the SCG, but not the nodose, as
one. (D) Bright-field image of hybridized embryo shown in F. (E)
ontinues in nodose. (F) PAC1 receptor expression is maintained in
FIG. 2. Immunocytochemical localization of PACAP ligand and
precursors are visualized by phase (A–D) or bright-field (E–H) mi
receptor (B, D, F, and H). (A, B) At 3 h, precursors appear as round
staining appears diffuse in cells, exhibiting variable levels of int
arrowhead. PAC1 receptor staining at 3 h (F) is similar to the pept
rocesses, whereas the appearance of doublets indicates precursors
igand appears as intense signal restricted to cell cytoplasm (G, arrowdistributed over the neuroblasts (H) and down processes (arrows). In th
whereas another is unstained (arrowhead), an infrequent observation. B
Copyright © 2000 by Academic Press. All rightrevious studies of neurotrophins indicate that the prenatal
recursor population depends on NT3 (Birren et al., 1993;
iCicco-Bloom et al., 1993; Ernfors et al., 1994; Farinas et
l., 1994; ElShamy et al., 1996; Wyatt et al., 1997) whereas
postnatal neurons rely on target-derived NT3 and NGF
(Coughlin and Collins, 1985; Levi-Montalcini, 1987; Crow-
ley et al., 1994). To determine whether PACAP signaling is
involved in promoting the appearance of neurotrophin
receptors and the elaboration of target fibers, we defined
peptide effects on neurite ourgrowth and expression of trkC
and trkA. As subpopulations of neuroblasts respond to
PACAP by enhanced mitosis and survival, in the following
studies, we attempted to minimize potentially confounding
effects by including maximally mitogenic insulin in all
cultures (DiCicco-Bloom et al., 1993; Pincus et al., 1994).
After 24 h of incubation, PACAP exposure increased the
roportion of cells bearing neurites fourfold (control 21 6
.7%; PACAP 81 6 1.2%; mean % 6 SEM, N 5 6; P ,
.001) an effect that, in addition to survival promotion, is
onsistent with peptide trophic activity. These processes
ere long and frequently branched and exhibited character-
stic varicosities (Figs. 5A and 5C). The magnitude and time
ourse of these neuritogenic effects were very similar to
hose reported previously for VIP (Pincus et al., 1990a,b).
To define effects on trk expression, sympathetic neuro-
lasts were incubated in control or PACAP-containing
edium for 24 h and fixed for immunocytochemical anal-
sis. Significantly, trkC and trkA immunoreactivities were
enerally similar in cells cultured in control medium. In
eneral, greater than 80% of control cells exhibited weak or
oderate intensity staining for both receptors, localized to
perinuclear distribution with a cytoplasmic crescent,
resumably reflecting the Golgi region. Thus most regions
f cell cytoplasm in control cultures were devoid of immu-
oreactive signal (Fig. 5). In contrast, after PACAP treat-
ent, greater than 80% of neuroblasts exhibited intense
ytoplasmic signal that was diffusely distributed through-
ut the entire cytoplasm and neuritic processes (Fig. 5).
onic rat by in situ hybridization. Bright-field (A, D) and dark-field
4.5 (A–C) and E17.5 (D–F) rat embryos. (A) Bright-field image of
A transcripts are expressed diffusely in the SCG and neighboring
arotid arteries. Also note PACAP transcripts in dorsal root ganglia
s (as previously reported, Waschek et al., 1998). (C) PAC1 mRNA
l as in DRG and spinal cord, especially in proliferative ventricular
AP transcripts are markedly reduced in SCG, though expression
.5 SCG. Bar, 200 mM.
1 receptor proteins in dissociated SCG neuroblasts. E15.5 SCG
opy after immunostaining for PACAP (A, C, E, and G) or PAC1
s in various degrees of attachment to the culture dishes. PACAP
y (E), with positive signal indicated by arrows and negative by
C, D) At 24 h in control medium, some cells have grown neuritic
have divided in vitro (DiCicco-Bloom et al., 1990, 1993). PACAP
24 h (negative cell, arrowhead). PAC1 receptor staining is diffuselymbry
of E1
RN
the c
uron
wel
PAC
E17
PAC
crosc
cell
ensit
ide. (
that
s) byis field, one presumptive mitotic pair expresses receptor (bottom)
ar, 50 mM.
s of reproduction in any form reserved.
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204 DiCicco-Bloom et al.FIG. 3. Effects of PACAP and VIP on neuroblast DNA synthesis. (A) Sympathetic neuroblasts were incubated for 48 h in control medium
(no insulin) or in medium containing various concentrations of PACAP27 or PACAP38. At 24 h, cultures received 2 mCi/ml of
3H]thymidine ([3H]dT) and incorporation was assayed at 48 h. Experimental values represent the mean incorporation of three culture wells
and is expressed as cpm 6 SEM. Data were derived from one of two separate experiments with identical results. (B) Neuroblasts were
incubated in control medium or medium containing various concentrations of PACAP38 or VIP, and [3H]dT incorporation was assayed.ACAP38 was 1000-fold more potent than VIP. (C). Neuroblasts were incubated in control medium or medium containing 10 mM VIP, 10
nM PACAP38, or 10 mM VIP plus 10 nM PACAP38 and assayed for [3H]dT incorporation. Data represent means of values obtained in two
Copyright © 2000 by Academic Press. All rights of reproduction in any form reserved.
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205PACAP Regulation of Sympathetic DevelopmentQuantification indicated that PACAP increased intensely
staining trkC immunreactive cells by eightfold (Fig. 6).
Although PACAP also increased cell survival in the 24-h
cultures by 50%, this increase alone could not account
entirely for the marked change in trkC-positive neuro-
blasts, suggesting that the peptide enhanced trkC expres-
sion independent of survival promotion (Fig. 6).
In addition to effects on trkC expression, PACAP expo-
sure also enhanced trkA immunoreactivity. Using antibod-
ies to both the extracellular (trkAout) and the intracellular
(trkAin2) trkA domains, PACAP elicited a five- to eightfold
increase in intensely positive neuroblasts. These effects
were independent of survival promotion, since the peptide
increased cell number by only 25–50% (Fig. 6).
While the foregoing change in trkA immunoreactivity
may indeed reflect more protein expression per cell, en-
hanced signal may, alternatively, represent antigen redistri-
bution. To address this possibility, we examined trkA
expression using Western analysis, in which equal amounts
of total neuroblast proteins were compared after 24 h of
culture incubation. PACAP treatment increased trkA pro-
separate experiments, N 5 6 for each group, and are expressed as m
D) Sympathetic neuroblasts were incubated for 24 h in control m
(Ant., PACAP6-38, 1026 M), 10 nM PACAP38, or Ant. plus PACAP.
represent means of values obtained in two separate experiments, N
ACAP at P , 0.04. (E) Neuroblasts were incubated in control med
26
FIG. 4. Effects of PACAP on neuroblast survival. Neuroblasts
ere incubated in control medium or medium containing 10 nM
ACAP38 and cell number was assessed at 24 h. Data represent the
ercentage of cells counted at zero time (3 h) that were present the
ext day and are expressed as mean percentage of cells/dish 6 SEM.
Differs from control at P , 0.01.M), 10 M VIP, or VIP plus antagonist and assayed for incorporation a
experiments, N 5 8 for each group. *Differs from control at P , 0.01.
Copyright © 2000 by Academic Press. All rightein three- to fourfold (Fig. 7), whereas the peptide did not
lter levels of the constitutive enzyme, RNA polymerase II.
he increase in trkA content of the cultures therefore
arallels detection of more neuroblasts in the population
xpressing intense neurotrophin receptor immunoreactiv-
ty. These observations suggest that the PACAP system
ay be involved in regulating trk receptor expression
uring ontogeny, by eliciting either increased overall cellu-
ar differentiation or, potentially, selective trk induction,
uestions which will require further study.
PACAP Activation of Intracellular Second
Messengers
As PACAP and VIP activate a family of related receptors
exhibiting alternative splice variants and differential cou-
pling, we examined intracellular signaling since it is known
to be cell type specific. In recent work, we found that the
E15.5 sympathetic ganglion expresses the “hop” isoform of
the PAC1 receptor (Lu et al., 1998). To define coupling to
he cAMP pathway, we examined cAMP content after
xposing cultures to low and high concentrations of the
eptides. While a concentration of 1 mM of either peptide
ncreased cAMP content three- to fourfold, only PACAP at
.01 mM elicited a similar increase, consistent with both
eptides acting via the PAC1 receptor (Fig. 8).
In addition to cAMP, the hop isoform may couple to the
I pathway in some cellular contexts. PACAP exposure
licited a fivefold increase in PI turnover in vitro (Fig. 9),
uggesting that both pathways are activated by the peptide
n these developing neuroblasts. Furthermore, one down-
tream effector of PI turnover, that is, increased [Ca21]i, was
lso rapidly induced in all 17 cells examined following
ACAP treatment (Fig. 10). Significantly, both PI turnover
nd increased [Ca21]i are well-recognized signals activated
by mitogenic signals (Rozengurt, 1986; Pardee, 1989).
DISCUSSION
Our observations indicate that the PACAP ligand/
receptor system is expressed early in the developing sym-
pathetic nervous system, during the period of major neuro-
genesis. Cell localization studies suggest that the peptide
may affect the majority of precursor cells in autocrine/
paracrine fashion. PACAP stimulation enhanced precursor
mitosis, cell survival, and expression of neurotrophin recep-
ercent of control 6 SEM. *Groups differ from control at P , 0.02.
(no insulin) or in medium containing PAC1 receptor antagonist
h, [3H]dT was added and incorporation was assayed at 24 h. Data
for each group. *Differs from control at P , 0.02; **differs from
r medium containing PAC1 receptor antagonist (Ant. 1026 M, 1027ean p
edium
At 20
5 8
ium ot 24 h. Data represent means of values obtained in two separate
s of reproduction in any form reserved.
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206 DiCicco-Bloom et al.tors, the three principal mechanisms underlying long-term
population growth. Furthermore, the activation of cAMP,
PI, and [Ca21]i signaling pathways by PACAP provides a
basis for interactions with other ontogenetic regulatory
factors.
Ontogenetic Expression of PACAP Ligand and
PAC1 Receptor
Our observations of PACAP message and protein at
FIG. 5. Effects of PACAP on neuroblast expression of trk recep
containing medium for 24 h and then fixed and stained for trkC a
cultures are visualized by phase (A, C) and bright-field (B, D) micro
medium, many neuroblasts exhibit extended cytoplasmic lamellae
restricted to a perinuclear region and does not extend to the cellu
PACAP38 (10 nM) have an altered morphology, exhibiting short an
generally less extended soma cytoplasm. TrkC staining is more int
(arrow). Bar, 50 mM.E14.5–15.5 indicate that the peptide is expressed after
neural crest cells aggregate dorsolateral to the dorsal aorta
d
c
Copyright © 2000 by Academic Press. All righto form the SCG. PACAP is expressed in the SCG and the
eighboring nodose ganglion, whereas receptor expression
s restricted to the sympathetic population. The receptor
ontinues to be expressed through E17.5, spanning the
eriod of major neuron production (Rubin, 1985; Pincus et
l., 1994; Tyrrell and Landis, 1994). Our observation that
irtually all the cells express the PACAP system, comple-
enting reports of message and protein in whole ganglia
Lu and DiCicco-Bloom, 1997; Lu et al., 1998), suggests that
he peptide plays an autocrine/paracrine role specifically
Sympathetic precursors were incubated in control or PACAP38-
kA immunoreactivities. Control (A, B) and PACAP-treated (C, D)
after trkC immunocytochemistry using trkCin2. (A, B) In control
se limits are indicated by the arrow in A. TrkC signal, however, is
ge, indicated by the arrow in B. (C, D) Precursors incubated with
g, branched neuritic processes terminating in growth cones and a
after PACAP exposure and is distributed throughout the cell bodytors.
nd tr
scopy
, who
lar ed
d lonuring the period of proliferation. As mitosis draws to a
lose, local peptide sources may reduce, as PACAP mRNA
s of reproduction in any form reserved.
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207PACAP Regulation of Sympathetic Developmenttranscripts and protein are restricted to a subpopulation of
neurons after birth and during maturity (Brandenburg et al.,
1997). However, ligand may be provided by innervating
FIG. 6. Quantification of PACAP effects on neuroblast trk expres-
sion and cell number. Neuroblasts were incubated in control
medium or medium containing PACAP38 (10 nM) for 24 h, fixed,
and processed for trkC and trkA immunostaining as in Fig. 5. The
proportions of neuroblasts exhibiting intense trk immunoreactiv-
ity (A, C, E) and total cell number (B, D, F) were defined as described
under Methods, for trkC (A, B) and trkA (C–F). (A, B) The effects of
PACAP on trkCin2 immunoreactivity and cell number. (C, D) The
effects of PACAP on trkAout immunoreactivity and cell number.
(E, F) The effects of PACAP on trkAin2 immunoreactivity and cell
number. Data represent the mean 6 SEM percentage of cells
expressing intense signal (A, C, E) and mean cells per dish 6 SEM
(B, D, F). *Differs from control at P , 0.01.intermediolateral terminals (Rubin, 1985; Nielsen et al.,
1998) or potentially from the neighboring nodose. After
m
*
Copyright © 2000 by Academic Press. All rightirth, PACAP from presynaptic afferents serves to regulate
atecholamine and neuropeptide synthesis and release (May
nd Brass, 1995; Moller et al., 1997a,b; Beaudet et al., 1998).
Significantly, the developmentally regulated expression of
the PACAP system coincides with other regulators of
ganglion neurogenesis, including IGF-I, EGF, and FGF mi-
togenic signals (DiCicco-Bloom and Black, 1988, 1989;
DiCicco-Bloom et al., 1990; Zachenfels et al., 1995).
FIG. 7. PACAP effects on trkA protein levels detected by Western
analysis. After incubating neuroblasts in control or PACAP38 (10
nM)-containing medium for 24 h, cells were lysed and protein
extracts were electrophoresed, transferred, and probed for trkA
expression. (A) PACAP increased trkA signal three- to fourfold. (B)
RNA polymerase II (210 kDa) levels were similar in the same
control and PACAP samples run on parallel gels. (C) Coomassie
blue staining of filters after antibody probing reveals equal protein
loading of control and PACAP samples. Note that the image size
was reduced to conserve space.
FIG. 8. Peptide effects on cAMP levels in sympathetic cultures.
Neuroblasts were incubated for 24 h and then exposed to VIP or
PACAP38 at indicated concentrations for 10 min and then col-
lected to determine cAMP content. Data are expressed as means 6
EM picomoles of cAMP per dish. PACAP at 0.01 mM (10 nM) was
aximally effective, whereas this dose of VIP was without effect.
Groups differ from control at P , 0.05.
s of reproduction in any form reserved.
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208 DiCicco-Bloom et al.PACAP Stimulation of Sympathetic Neuroblast
Mitosis and Survival
Previous study indicates that two mechanisms contrib-
ute to precursor proliferation. Factors may directly stimu-
late entry of precursors into the cell cycle. Alternatively,
signals may promote survival of the dividing precursor
population, allowing mitotic cells and newly born neurons
to survive and accumulate (DiCicco-Bloom et al., 1993; Lu
et al., 1996). Our studies suggest that PACAP possesses
both functions. PACAP elicited a 4-fold increase in neuro-
blast DNA synthesis, the magnitude of which was compa-
rable to other mitogens, such as insulin and IGF-I, as well as
previously studied VIP (DiCicco-Bloom and Black, 1988,
1989; DiCicco-Bloom et al., 1990; Pincus et al., 1990a,b,
1991, 1994). PACAP, however, was 1000-fold more potent
than VIP. Furthermore, the selective PAC1 receptor antag-
nist entirely blocked VIP mitogenic activity, even when
resent at 10-fold lower concentration, suggesting that the
eptides both acted via the PAC1 receptor. Indeed, the vast
ajority of precursors expressed PAC1 receptor protein,
defined using highly specific antiserum, consistent with
our previous detection of receptor mRNA (Lu et al., 1998).
As PACAP exhibited considerable effects on neuroblast
survival (see below), which may also increase observed
[3H]dT incorporation at 24–48 hours, we employed a brief
-h culture paradigm, in which minimal cell death pre-
luded trophic effects (Lu et al., 1996). While there was no
ifference in group cell numbers, PACAP treatment in-
reased DNA synthesis 32% and the proportion of mitotic
ells by 17%, indicating that the ligand can directly stimu-
ate mitogenesis, independent of survival effects (Lu et al.,
996). While this was a small effect, the 6-h time period is
FIG. 9. Effects of PACAP on inositol lipid turnover. Neuroblasts
were incubated for 24 h in control medium and then exposed to
vehicle (control) or PACAP38 (10 nM) for 30 min and processed for
PI turnover. Data are expressed as means 6 SEM cpm per group.
*Differs from control at P , 0.01.rief compared to the apparent cycle time, ;24 h (DiCicco-
loom et al., 1990), and cells were still recovering from
Copyright © 2000 by Academic Press. All rightissociation. Similar mitogenic stimulation was observed
or both the mitogen, insulin, and VIP in this paradigm (Lu
t al., 1996). In marked contrast, the trophic factor NT3 did
ot stimulate mitosis at all under these conditions, though
he trophin rescued mitotic cells at later times when cell
eath was ongoing (DiCicco-Bloom et al., 1993; Lu et al.,
996). In sum, these studies suggest that PACAP has direct
itogenic activity, effects of which may be enhanced in
uture studies by using proliferation-promoting conditions,
uch as high cell density and alternative substrates.
In addition to mitogenic stimulation, our studies demon-
trate that PACAP promotes neuroblast survival. Whereas
ess than 40% of neuroblasts survived in control media,
0% of plated cells were present after PACAP treatment,
he peptide increasing survival greater than twofold. More-
ver, even in the presence of the mitogen insulin, PACAP
nhanced neuroblast cell number 25–50%, further support-
ng PACAP trophic functions. In previous studies, VIP also
ppeared to elicit survival independent of mitogenic action
Pincus et al., 1990a,b, 1994). While our studies demon-
trate that activation of PAC1 receptors supports sympa-
hetic survival, effects are mainly limited to the period of
euroblast proliferation (Pincus et al., 1994), suggesting
hat trophic requirements change during development. In-
eed, as SCG neurons mature, PAC1 receptor activation
rescues progressively fewer cells, whereas neurons become
increasingly dependent on NGF (Coughlin and Collins,
1985; Pincus et al., 1994; Wyatt and Davies, 1995). Thus, in
aggregate, autocrine PACAP, or high concentrations of VIP,
act via the PAC1 receptor to independently stimulate entry
nto the cell cycle as well as precursor survival, promoting
wo primary mechanisms underlying cell proliferation
DiCicco-Bloom et al., 1993; Lu et al., 1996).
The mitogenic and tophic effects of the PACAP ligand/
eceptor system differ significantly from actions of other
ecently defined signaling systems that exhibit prenatal
ctivity, including NT3/trkC, HGF/Met, and GDNF
amily/Ret-GFRa1-3. NT3 promotes only survival of the
recursor population (Birren et al., 1993; DiCicco-Bloom et
l., 1993; Lu et al., 1996) and may also act at postnatal
tages as a target-derived trophic factor (ElShamy et al.,
996; see below). HGF acts via Met as an autocrine factor in
renatal neuroblasts to stimulate survival and promote
rocess growth and branching, but is devoid of mitogenic
ctivity (Maina et al., 1998; Yang et al., 1998). However, the
resence of two mitogens, insulin and laminin, may have
asked potential cell cycle effects (Maina et al., 1998).
ostnatally, HGF served as an autocrine regulator of process
rowth rate and density, but had no survival effects (Yang et
l., 1998). Finally, the GDNF family has prenatal trophic
ffects in sympathetics. In the chick, neurturin may pre-
ede GDNF trophic function, reflecting expression of GFRa
coreceptors (Buj-Bello et al., 1995; Trupp et al., 1995; Forgie
et al., 1999). Some evidence, however, also suggests effects
on proliferating precursors (Buj-Bello et al., 1995). In the
mouse, deletion of the common signaling Ret tyrosine
kinase receptor leads to an absence of the SCG, with major
s of reproduction in any form reserved.
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209PACAP Regulation of Sympathetic Developmentcell loss occurring at the height of precursor proliferation at
E12, suggesting roles in either survival or mitogenesis
(Durbec et al., 1996). The GDNF ligands are expressed
locally as well as in target fields (Trupp et al., 1995). While
here is some cross-talk, GDNF, neurturin, and artemin act
ia their respective GFRas to support survival and neurite
outgrowth of 10–60% of P1 SCG neurons, depending on
experimental paradigm, and their activities overlap with
one another and NGF, suggesting that the factors cooperate
in regulating postnatal neuronal survival (Buj-Bello et al.,
1995; Trupp et al., 1995; Creedon et al., 1997; Baloh et al.,
998). In contrast to the foregoing signals, the PACAP
ystem plays a distinct role during the critical period of
mbryonic neurogenesis. Although PACAP does not pro-
ote survival of P1 sympathetics, interactions of the pep-
ide with other factors remain a fertile area for future work.
PACAP Enhances Trk Receptor Expression
After neurogenesis, the survival and maintenance of
sympathetic neurons depend in part on the neurotrophins,
NT3 and NGF (Birren et al., 1993; DiCicco-Bloom et al.,
FIG. 10. Effect of PACAP exposure on [Ca21]i in cultured sympath
on glass coverslips and analyzed using Fura-2 calcium ratio ima
epresentative neuroblasts at various times before and after the add
M in [Ca21]i after PACAP exposure. (B) Fluorescent image of four1993; Wyatt and Davies, 1995). Genetic deletion of either
factor results in the late prenatal (postneurogenetic) loss of
f
m
Copyright © 2000 by Academic Press. All rightCG neurons (Crowley et al., 1994; Farinas et al., 1994;
lShamy et al., 1996; Wyatt et al., 1997). Significantly,
ostnatal administration of NT3 or NGF antiserum results
n death of an overwhelming majority of neurons, suggest-
ng that they both serve as target-derived survival factors as
ell (Zhou and Rush, 1995; Tafreshi et al., 1998). While
imilar major losses occur after deleting trkA, studies of
rkC suggest that it is dispensible for sympathetic survival
Fagan et al., 1996). Studies of trkA regulation during
evelopment, using cell lines, immunoselected precursors,
nd primary neurons in culture and in vivo, support con-
icting views of the role of epigenetic versus cell autono-
ous mechanisms (Birren et al., 1992, 1993; Verdi et al.,
996; Wyatt and Davies, 1995; Wyatt et al., 1997). We chose
o examine whether PACAP plays a role in expression of
arget factor receptors. PACAP treatment increased five- to
ightfold the proportion of neuroblasts exhibiting intense
rkC and trkA immunoreactivity and enhanced total trkA
rotein, suggesting that PACAP may contribute to the
xpression of receptors for target-derived neurotrophins.
owever, as trkC diminishes while trkA increases during
ntogeny, other mechanisms likely modulate PACAP ef-
euroblasts. Precursors were incubated in control medium for 24 h
(A) Individual plots of intracellular Ca21 concentrations in four
of 100 nM PACAP. All four cells exhibited an increase of over 100
roblasts at 380-nm excitation.etic n
ging.ects. Regardless, future studies will be necessary to deter-
ine whether enhanced trk expression reflects increased
s of reproduction in any form reserved.
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210 DiCicco-Bloom et al.overall cellular differentiation versus selective induction of
trk gene products. From another perspective, whereas ge-
netic mutants in NT3 or NGF systems exhibit death of
most SCG neurons prenatally, approximately 30–50% of
cells remain (Crowley et al., 1994; Farinas et al., 1994;
lShamy et al., 1996), potentially due to PACAP trophic
upport of a select ganglion subpopulation.
PACAP Activation of Multiple Intracellular Signals
Receptor binding to PACAP or VIP activates signaling via
both the cAMP and the PI pathways. The 1000-fold greater
potency of PACAP is compatible with function of the PAC1
receptor. In previous study, we defined the presence of the
hop isoform in embryonic ganglia, which is known to
couple efficiently to the dual pathways in some cell types
(Lu et al., 1998; Spengler et al., 1993). Moreover, PACAP
reatment rapidly elicits increased [Ca21]i, presumably a
onsequence of enhanced PI turnover, generation of IP3, and
Ca21 release from intracellular stores, as observed in cell
ines (Delporte et al., 1993). In contrast, entry of extracel-
ular Ca21 via calcium channels was not required for VIP-
nduced mitosis in previous studies, whereas it played a
ajor role in mitogenic effects of KCl-induced depolariza-
ion (DiCicco-Bloom and Black, 1989; Pincus et al., 1991).
The signaling pathways activated by PACAP in primary
ympathetic neuroblasts parallels those defined in neural
umor cell lines, especially neuroblastoma and PC12. The
ctivation of cAMP and PI has been most directly linked to
ifferentiation, as evidenced by neurite outgrowth (Deutsch
nd Sun, 1992; Deutsch et al., 1993; Hernandez et al., 1995).
everal studies suggest that PACAP-induced differentiation
epends on activation of the Raf/MEK/MAPK (ERK1/2)
athway, though requirements for cAMP versus PI and
ownstream protein kinase C remain unresolved (Colbert
t al., 1994; Frodin et al., 1994; Young et al., 1994; Barrie et
l., 1997). Nonetheless, cAMP agonists themselves elicit
eurite outgrowth in cell lines (Deutsch and Sun, 1992;
eutsch et al., 1993; Young et al., 1994) and in the primary
euroblasts (Pincus et al., 1990b).
As regards survival promotion, enhanced survival elicited
y PAC1 receptor stimulation in embryonic precursors was
eproduced by cAMP pathway activation (Pincus et al.,
990b). The cAMP pathway may also play a survival role in
ostnatal NGF-dependent neurons (Rydel and Greene,
988; Edwards et al., 1991; Martin et al., 1992; Virdee and
olkovsky, 1995). In contrast, PAC1 signaling is not trophic
or acutely dissociated P1 SCG neurons incubated in serum-
ree media (Pincus et al., 1994), though effects after with-
rawal of chronic NGF remain to be defined. Significantly,
s neurotrophins similarly activate some of these pathways,
specially phosphorylated cAMP-responsive element-
inding protein (P-CREB; Schadlow et al., 1992; Kaplan and
iller, 1997; Lu DiCicco-Bloom, 1997; Segal and Green-
erg, 1996), it is likely that PACAP collaborates with the
rophins during development, as suggested by several stud-
es (Frodin et al., 1994; Young et al., 1994; Barrie et al.,
Copyright © 2000 by Academic Press. All right997). Finally, all of the foregoing pathways have important
oles in mitogenesis, though specific effects clearly depend
n the cellular context (Baserga, 1985; Rozengurt, 1986;
ardee, 1989; DiCicco-Bloom and Black, 1989; Pincus et al.,
990b, 1991; Cowley et al., 1994).
More generally, our observations of early PACAP ligand/
eceptor system expression and functions in sympathetic
ntogeny lay a basis for investigating peptide interactions
ith other signaling pathways in regulating proliferation,
urvival, and differentiation of multiple peripheral and
entral neuronal populations (DiCicco-Bloom, 1996; Lu and
iCicco-Bloom, 1997; Nielsen et al., 1998; Waschek et al.,
998).
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